5/28/2020 · The usual dose of RoActemra depends on the patient’s weight. If the patient weighs less than 30 kg: the dose is 162 mg (the content of 1 pre-filled syringe), once every 3 weeks. If the patient weighs 30 kg or more: the dose is 162 mg (the content of 1 pre-filled syringe), once every 2 weeks.
The recommended posology is subcutaneous 162 mg once every week in combination with a tapering course of gluco corticoids. RoActemra can be used alone following discontinuation of glucocorticoids. RoActemra monotherapy should not be used for the treatment of acute relapses (see 4.4).
RoActemra 162 mg . RoActemra 162 mg may be available in the countries listed below. Ingredient matches for RoActemra 162 mg Tocilizumab. Tocilizumab is reported as an ingredient of RoActemra 162 mg in the following countries: Hungary Important Notice: The Drugs.com international database is in BETA release.
Product Name RoACTEMRA ® Active substance Tocilizumab Indication and conditions of use RoActemra 162 mg solution for injection in pre?filled syringe. Giant cell arteritis (GCA or temporal arteritis) is a systemic inflammatory disease of blood vessels.
3/5/2021 · Patients were randomised in a 1:1 ratio to receive weekly subcutaneous injections of 162 mg of Actemra/ RoActemra or placebo during the 48-week, double-blinded, placebo-controlled period, followed by open-label Actemra/ RoActemra 162 mg administered subcutaneously every week for another 48 weeks.
the SmPC for RoActemra 162 mg solution for injection in pre-filled pen has been aligned with the approved indications for RoActemra 162 mg solution for injection in pre-filled syringe to include active systemic juvenile idiopathic arthritis (sJIA) and juvenile idiopathic polyarthritis. The use of the pre filed pen is from the age of 12 years.
RoActemra on pakattu 0,9 ml:n esitäytettyyn ruiskuun, joka sisältää 162 mg tosilitsumabi-injektionestettä, liuosta. Jokainen pakkaus sisältää 4 esitäytettyä ruiskua. Monipakkaus sisältää 12 esitäytettyä ruiskua (3 pakkausta, joissa kussakin 4 esitäytettyä ruiskua). Kaikkia pakkauskokoja ei välttämättä ole myynnissä.
RoActemra 162 mg esitäytetty kynä sisältää 0,9 ml liuosta esitäytetyssä ruiskussa (tyypin I lasia), jossa on valmiiksi kiinnitetty neula. Ruiskussa on jäykkä neulansuojus (elastomeerisuljin, jossa polypropenikuori) ja männänpysäytin (fluororesiinipäällysteistä butyylikumia).
